| Renin–angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure TG Von Lueder, SJ Sangaralingham, BH Wang, AR Kompa, D Atar, ... Circulation: Heart Failure 6 (3), 594-605, 2013 | 184 | 2013 |
| The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic peptide SJ Sangaralingham, BK Huntley, FL Martin, PM McKie, D Bellavia, T Ichiki, ... Hypertension 57 (2), 201-207, 2011 | 145 | 2011 |
| Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease A Buglioni, V Cannone, A Cataliotti, SJ Sangaralingham, DM Heublein, ... Hypertension 65 (1), 45-53, 2015 | 106 | 2015 |
| Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection FL Martin, PM McKie, A Cataliotti, SJ Sangaralingham, J Korinek, ... American Journal of Physiology-Regulatory, Integrative and Comparative …, 2012 | 98 | 2012 |
| Adoption of sacubitril/valsartan for the management of patients with heart failure LR Sangaralingham, SJ Sangaralingham, ND Shah, X Yao, SM Dunlay Circulation: Heart Failure 11 (2), e004302, 2018 | 86 | 2018 |
| Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year … PM McKie, A Cataliotti, SJ Sangaralingham, T Ichiki, V Cannone, ... Mayo Clinic Proceedings 86 (12), 1154-1160, 2011 | 85 | 2011 |
| CD-NP: a novel engineered dual guanylyl cyclase activator with anti-fibrotic actions in the heart FL Martin, SJ Sangaralingham, BK Huntley, PM McKie, T Ichiki, HH Chen, ... PloS one 7 (12), e52422, 2012 | 73 | 2012 |
| Cardiorenal syndrome: Multi‐organ dysfunction involving the heart, kidney and vasculature F Savira, R Magaye, D Liew, C Reid, DJ Kelly, AR Kompa, ... British journal of pharmacology 177 (13), 2906-2922, 2020 | 70 | 2020 |
| Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis T Ichiki, G Boerrigter, BK Huntley, SJ Sangaralingham, PM McKie, ... American Journal of Physiology-Regulatory, Integrative and Comparative …, 2013 | 62 | 2013 |
| Comparative effectiveness of sacubitril-valsartan versus ACE/ARB therapy in heart failure with reduced ejection fraction NY Tan, LR Sangaralingham, SJ Sangaralingham, X Yao, ND Shah, ... JACC: Heart Failure 8 (1), 43-54, 2020 | 61 | 2020 |
| Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications T Ichiki, JA Schirger, BK Huntley, FV Brozovich, JJ Maleszewski, ... Journal of molecular and cellular cardiology 75, 199-205, 2014 | 56 | 2014 |
| Urinary C-type natriuretic peptide: a new heart failure biomarker R Zakeri, SJ Sangaralingham, SM Sandberg, DM Heublein, CG Scott, ... JACC: Heart Failure 1 (2), 170-177, 2013 | 56 | 2013 |
| Pro–B-Type natriuretic peptide-1-108 processing and degradation in human heart failure BK Huntley, SM Sandberg, DM Heublein, SJ Sangaralingham, ... Circulation: Heart Failure 8 (1), 89-97, 2015 | 55 | 2015 |
| Differential regulation of ANP and BNP in acute decompensated heart failure: deficiency of ANP SH Reginauld, V Cannone, S Iyer, C Scott, K Bailey, J Schaefer, Y Chen, ... JACC: Heart Failure 7 (10), 891-898, 2019 | 52 | 2019 |
| A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertension PM McKie, A Cataliotti, G Boerrigter, HH Chen, SJ Sangaralingham, ... Hypertension 56 (6), 1152-1159, 2010 | 51 | 2010 |
| Discovery of O-glycans on atrial natriuretic peptide (ANP) that affect both its proteolytic degradation and potency at its cognate receptor LH Hansen, TD Madsen, CK Goth, H Clausen, Y Chen, N Dzhoyashvili, ... Journal of Biological Chemistry 294 (34), 12567-12578, 2019 | 48 | 2019 |
| Circulating C-type natriuretic peptide and its relationship to cardiovascular disease in the general population SJ Sangaralingham, PM McKie, T Ichiki, CG Scott, DM Heublein, ... Hypertension 65 (6), 1187-1194, 2015 | 48 | 2015 |
| CD-NP: an innovative designer natriuretic peptide activator of particulate guanylyl cyclase receptors for cardiorenal disease PM McKie, SJ Sangaralingham, JC Burnett Current heart failure reports 7, 93-99, 2010 | 47 | 2010 |
| Cardiorenal fibrosis and dysfunction in aging: imbalance in mediators and regulators of collagen SJ Sangaralingham, BH Wang, L Huang, S Kumfu, T Ichiki, H Krum, ... Peptides 76, 108-114, 2016 | 44 | 2016 |
| Urinary C-type natriuretic peptide excretion: a potential novel biomarker for renal fibrosis during aging S Jeson Sangaralingham, DM Heublein, JP Grande, A Cataliotti, AD Rule, ... American Journal of Physiology-Renal Physiology 301 (5), F943-F952, 2011 | 42 | 2011 |
Andrew RuleMayo Clinic在 mayo.edu 的电子邮件经过验证
